openPR Logo
Press release

Diabetes Therapeutics Market Report involving Key Players:AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk, Sanofi S.A.

02-14-2020 08:45 PM CET | Health & Medicine

Press release from: Western Market Research

Diabetes Therapeutics Market Report involving Key

The global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Diabetes therapeutics are drugs used by diabetic patients to restore the blood glucose metabolism to a normal state.

Ask for a free Sample- https://westernmarketresearch.com/market-report/2379/Diabetes-Therapeutics-Market-by-Product-[Injectabl#sample

The factors that drive the global diabetes therapeutics market include rise in geriatric population, increase in prevalence of diabetes worldwide, sedentary lifestyle of people, development of affordable & effective diabetes therapeutics, growth in awareness among people about self-management of diabetes, and support from the government However, side effects of diabetic drugs and stringent approval process for the same restrict the market growth. Moreover, surge in awareness about diabetes care and market potential in developing regions are expected to provide numerous opportunities for market growth.

The global diabetes therapeutics market is segmented on the basis of product and region. Based on product, it is bifurcated into injectable and oral-antidiabetic drugs (OAD). Injectable are further categorized into insulin, glucagon-like peptide-1 (GLP-1) receptor agonists, and amylinomimetic drug. Oral-antidiabetic drugs (OAD) segment is further divided into biguanides, sulfonylureas, thiazolidinediones, alpha-glucosidase inhibitors, dipeptidyl peptidase IV (DPP-4) inhibitors, meglitinides, and sodium-glucose cotransporter-2 (SGLT2) inhibitors. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
Key market players are profiled and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.

Click and ask for instant 30% discount @ WMR - https://westernmarketresearch.com/market-report/2379/Diabetes-Therapeutics-Market-by-Product-[Injectabl#inquiry


KEY MARKET SEGMENTS

BY PRODUCT

Injectables
Insulin
Glucagon-like Peptide-1 (GLP-1) Receptor Agonists/Incretin Mimetics
Amylin Analogue/Amylinomimetic Drugs
Oral-antidiabetic Drugs (OAD)
Biguanides
Sulfonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
Dipeptidyl Peptidase IV (DPP-4) Inhibitors/Gliptins
Meglitinides
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors/Gliflozins

BY REGION

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Buy this Report Now - https://westernmarketresearch.com/buynow.php?id=2379

LIST OF KEY PLAYERS PROFILED IN THE REPORT

AstraZeneca plc
Boehringer Ingelheim GmbH
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Sanofi S.A.
Takeda Pharmaceutical Company Limited

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

Astellas Pharma Inc.
Biocon Limited
Diasome Pharmaceuticals, Inc.
Generex Biotechnology Corp.
MannKind Corporation
Pfizer Inc.

Read in Details click on below - https://westernmarketresearch.com/market-report/2379/Diabetes-Therapeutics-Market-by-Product-[Injectabl

For More info.
Contact.

Kritarth Arun (Marketing & Sales)
https://www.linkedin.com/company/western-market-research/?originalSubdomain=in
WESTERN MARKET RESEARCH
Office No.6, CN7, Survey No. 94-95
Pune, Maharashtra, India.
Email- info@westmarketreport.com
Phone No (US)+1 (650) 741-1345
Phone No (IN) +91 7757044254
https://westernmarketresearch.com/

NEAR INDIRA SHANKAR NAGARI, BHUSARI COLONY,KOTHRUD

Western Market Research is a global player, among top market research companies, with niche in intelligent industry analysis, business report, syndicate, comprehensive and secondary research report having in-depth data analysis based on history trends and forecast, segmentation, major players, market size and market share. Our research firm comprises of analysts with insights on market overview providing business consulting services resulting in breakthrough primary and secondary market research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Therapeutics Market Report involving Key Players:AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk, Sanofi S.A. here

News-ID: 1933318 • Views:

More Releases from Western Market Research

Reverse Osmosis (RO) Membrane Market- Top Key Players- Axeon Water Technologies, Dow Water & Process Solutions, General Electric, GE Water & Process Technologies
Reverse Osmosis (RO) Membrane Market- Top Key Players- Axeon Water Technologies, …
Reverse Osmosis (RO) Membrane Market Report is expected to grow at CAGR 12.5% by 2028. Reverse Osmosis (RO) Membrane Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. Reverse osmosis is a technology used to remove most contaminants from water by pushing water under pressure through a semi-permeable membrane. Reverse osmosis (RO) membranes play a key role in
Global Metaverse Market is expected to register a CAGR at 45.8% by 2028 ,Top Key Players- Facebook Inc, AR Solution Cop, Nvidia Corporation, Nextech AR Solutions Corp, Unity Technologies Inc, Lilith Games, Roblox Corporation, Tencent Holdings Ltd, ByteDan
Global Metaverse Market is expected to register a CAGR at 45.8% by 2028 ,Top Key …
The Metaverse Market is expected to register a CAGR at 45.8% by 2028 Metaverse Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. The metaverse can be defined as a simulated digital surroundings that makes use of augmented reality (AR), virtual truth (VR), and block chain, in conjunction with concepts from social media, to create areas for wealthy user interplay
Nuclear Medicine radiopharmaceuticals Stable Isotopes Market, Top Key Players- Bayer AG, GE Company, Cardinal Health, Jubilant Life science, Lantheus Medical Imaging, Siemens AG
Nuclear Medicine radiopharmaceuticals Stable Isotopes Market, Top Key Players- B …
Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report is expected to grow at CAGR XX% by 2028. Nuclear Medicine radiopharmaceuticals Stable Isotopes Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. Increased application of radioisotopes, increased public awareness, usage of SPECT/CT and PET/CT (hybrid imaging) imaging scanners, and technological advancements are driving the growth of the nuclear medicine market. Additionally,
Telemedicine Technologies Market Report is to growing at CAGR 20.20% by 2022, Size, Share, Forecast 2028, Aerotel Medical Systems Ltd, Alcatel-Lucent, At&T, Amd Telemedicine Inc, American Telecare Inc, Agfa Healthcare Nv
Telemedicine Technologies Market Report is to growing at CAGR 20.20% by 2022, Si …
Telemedicine Technologies Market Report is to growing at CAGR 20.20% by 2022. Telemedicine Technologies Market Report was 18.60% CAGR in 2018 and is expected to reach $XX Billion by the forecasted period 2022 to 2028. Telemedicine refers exclusively to the provision of health services and education at a distance, through the use of telecommunications technology. The use of telemedicine technologies to provide clinical services to patients. The technology is often

All 5 Releases


More Releases for Diabetes

Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their
Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth
According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025. Research and Development Pursuits to Introduce Novel Products Stokes Growth The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food